Molecular Imaging Finds Link Between Obesity and Low Estrogen Levels

A new study presented at SNM’s 58th Annual Meeting could throw open the door to a recently established area of obesity research. Investigators have developed a novel molecular imaging agent that targets estrogenic mechanisms in the brain to find out what effect an enzyme called aromatase has on body mass index (BMI), a measurement of body fat based on height and weight. Aromatase is crucial for the production of estrogen in tissues throughout the body, including the brain.

According to the World Health Organization, worldwide obesity has more than doubled since 1980. As of 2008, an estimated 1.5 billion adults were overweight, and in 2010 nearly 43 million children under the age of five were overweight.

“We used this imaging agent to evaluate the amount of aromatase activity in the brain regions related to eating behaviors, such as the hypothalamus and amygdala, in both overweight and normal weight subjects. We were really surprised to see the highest correlation between aromatase availability and BMI happening in the amygdala, which controls emotional memory,” says Gene-Jack Wang, MD, senior scientist and chair of the medical department at Brookhaven National Laboratory, Upton, N.Y. “Our eating is not only controlled by the hunger centers in the brain. It is also related to memory, and that could have a big impact on a person’s eating behavior. This agent could potentially translate into a number of new studies evaluating estrogen and obesity, food intake and appetite suppression.”

For this study, five healthy overweight subjects and 13 normal-weight subjects of the same age were chosen to undergo positron emission tomography, a molecular imaging technique that provides digital representations of physiological functions of the body. Subjects were injected before imaging with the novel imaging agent (C-11)vorozole, which is composed of a medical isotope bound with an aromatase inhibitor that binds strongly with the active sites of the enzyme in the brain. This allowed investigators to track and quantify the availability of this enzyme to selected areas of the brain associated with hunger and feeding behavior.

A significant correlation was found between high BMI of subjects and decreased uptake of the aromatase inhibitor. Imaging agent uptake was decreased in the hypothalamus (25 percent less), thalamus (27 percent less) and amygdala (30 percent less) in subjects with high BMI. This means that there was less availability of the enzyme in these selected brain regions. There was also a strong inverse correlation between low BMI and imaging agent uptake in the amygdala, meaning BMI was less in subjects showing higher aromatase availability. These findings suggest that there is decreased availability of aromatase in the brains of overweight subjects, conceivably leading to reduced availability of estrogen and potentially less control over appetite and food intake, resulting in weight gain; however, further studies need to be conducted to validate the relationship between estrogen synthesis and high BMI.

Future studies could be introduced to screen eating behaviors of obese subjects in order to further validate the correlation between BMI and estrogen availability in the brain. Based on the current research, theoretically the less estrogen available to the brain, the less control patients may have over their appetite. Studies moderating estrogen and feeding behavior could result in novel drugs for appetite suppression and perhaps even reduction of BMI. This is just the first step toward discovering the mechanisms behind appetite, BMI and estrogen availability.

Read more http://www.sciencedaily.com/releases/2011/06/110606131709.htm

Share

Posted: June 7th, 2011 under Uncategorized.

RSS Medical Imaging News

  • Possible cause of common dementia found, opening avenues for treatment October 30, 2014
    A major cause of dementia has been potentially discovered, scientists report. In the type of dementia studied, there is damage to the white matter (nerve fibres) of the brain apparent on computerized tomography (CT) and magnetic resonance imaging (MRI) scans of older individuals.
  • Novel ultrasound technology to screen for heart conditions developed by engineers October 29, 2014
    Engineers have determined, for the first time, the impact of a ring-shaped vortex on transporting blood flow in normal and abnormal ventricles within the human heart, and have developed a novel ultrasound technology that makes screening cheaper and much easier, making it possible to reach a large number of people and even infants.
  • Brain abnormalities found in chronic fatigue patients October 29, 2014
    An imaging study has found distinct differences between the brains of patients with chronic fatigue syndrome and those of healthy people.
  • Sensors used to monitor dangerous hits on football field October 29, 2014
    In football, a tackle can supply 100 G’s of force or more, well above the amount that can cause a concussion and more than 10 times the force of an F-16 jet roll maneuver. Now, researchers are using the helmets of Gator football players to help measure the force of on-field hits as part of ongoing efforts to better understand and prevent concussions and trea […]
  • New technology shows promise for delivery of therapeutics to the brain October 28, 2014
    Researchers have created “a tool for blood-barrier-brain disruption that uses bursts of sub-microsecond bipolar pulses to enhance the transfer of large molecules to the brain.” According to the authors, the current medical use of chemotherapy to treat brain cancer can be inefficient because of the blood-brain-barrier that impedes the delivery of drugs out of […]
  • Tomosynthesis improves cancer detection in women with dense breast tissue October 28, 2014
    As of October 2014, 19 states have enacted laws requiring women to be directly informed if they have dense breasts and would benefit from supplemental screening. However, the recommended type of supplemental screening for women with dense breasts remains unclear. With 15 additional states considering similar laws and federal legislation introduced, physician […]
  • Preventative action prior to brain surgery: Ultra-high-field MRI reveals language centers in brain in much more detail October 28, 2014
    It is now possible, for the first time, to demonstrate that the areas of the brain that are important for understanding language can be pinpointed much more accurately using ultra-high-field MRI (7 Tesla) than with conventional clinical MRI scanners. This research helps to protect these areas more effectively during brain surgery and avoid accidentally damag […]
  • Ultrasound guides tongue to pronounce 'R' sounds October 27, 2014
    Using ultrasound technology to visualize the tongue’s shape and movement can help children with difficulty pronouncing “r” sounds, according to a small study. The ultrasound intervention was effective when individuals were allowed to make different shapes with their tongue in order to produce the "r" sound, rather than being instructed to make a sp […]
  • Brain development in utero observed by researchers October 27, 2014
    New investigation methods using functional magnetic resonance tomography (fMRT) offer insights into fetal brain development. These "in vivo" observations will uncover different stages of the brain's development. A research group has observed that parts of the brain that are later responsible for sight are already active at this stage.
  • New hope for potential prostate cancer patients October 25, 2014
    It has been more than 30 years since the last major advancement in prostate cancer screening technology, and the latest advancement is now available in the United States. It is estimated that 2014 will see more than 240,000 new cases of prostate cancer, and more than 29,000 deaths from the disease.

News Items

Links